paroxysmal nocturnal hemoglobinuria (PNH) | Page 16 | Aplastic Anemia and MDS International Foundation

paroxysmal nocturnal hemoglobinuria (PNH)

Long-term outcome of fludarabine-based reduced intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuria

Author(s): 
Pantin J, Tian X, Geller N, Ramos C, Cook L, Cho E, Scheinberg P, Vasu S, Khuu H, Stroncek D, Barrett J, Young NS, Donohue T, Childs RW
Primary Author: 
Pantin J
Journal Title: 
Biol Blood Marrow Transplant
Original Publication Date: 
May 2014

Paroxysmal nocturnal hemoglobinuria (PNH) is characterized by intravascular hemolysis,

Selective splenic artery embolization for the treatment of thrombocytopenia and hypersplenism in paroxysmal nocturnal hemoglobinuria

Author(s): 
Araten DJ, Iori AP, Brown K, Torelli GF, Barberi W, Natalino F, De Propris MS, Girmenia C, Salvatori FM, Zelig O, Foà R, Luzzatto L
Primary Author: 
Araten DJ
Journal Title: 
J Hematol Oncol
Original Publication Date: 
Mar 2014

BACKGROUND:

PNH is associated with abdominal vein thrombosis, which can cause splenomegaly and hypersplenism. The